Larvol Delta - Equillium-Announces-Results-of-the-Phase-3-EQUATOR-Study-of-Itolizumab-in-FirstLine-Treatment-of-Patients-with-Acute-GraftVersusHost-Disease

Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma

https://www.businesswire.com/news/home/20250327334273/en/Equillium-Announces-Results-of-the-Phase-3-EQUATOR-Study-of-Itolizumab-in-First-Line-Treatment-of-Patients-with-Acute-Graft-Versus-Host-Disease

Mar 27, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next